Evidence map›Paper›PMID 34199867›Full record

ArticleInternational journal of molecular sciences2021

MiR-181a-5p Regulates NIS Expression in Papillary Thyroid Carcinoma.

Wojciech Gierlikowski, Katarzyna Broniarek, Łukasz Cheda, Zbigniew Rogulski, Marta Kotlarek-Łysakowska

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. MicroRNAs and Their Inhibition in ModulatingInternational journal of molecular sciences · 2025
    Article
  4. Article
  5. Article
  6. Role of miR‑181a‑5p in cancer (Review).International journal of oncology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Wojciech GierlikowskiDepartment of Internal Medicine and Endocrinology, Medical University of Warsaw, Banacha 1a, 02-097 Warsaw, Poland.ORCID 0000-0002-1706-4436
Katarzyna BroniarekFaculty of Medicine, Medical University of Warsaw, Żwirki i Wigury 61, 02-091 Warsaw, Poland.ORCID 0000-0002-7885-6314
Łukasz ChedaFaculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw, Żwirki i Wigury 101, 02-089 Warsaw, Poland.
Zbigniew RogulskiFaculty of Chemistry, Biological and Chemical Research Centre, University of Warsaw, Żwirki i Wigury 101, 02-089 Warsaw, Poland.
Marta Kotlarek-ŁysakowskaWarsaw Genomics, Żwirki i Wigury 101, 02-089 Warsaw, Poland.
Medical University of Warsaw · PLUniversity of Warsaw · PL

Funding

European Thyroid Association Research Grant 2018Narodowe Centrum Nauki 2015/17/N/NZ2/01856
6 · The paper itself

Abstract

NIS is a potent iodide transporter encoded by the

Indexed as

Gene Expression Regulation, NeoplasticBiomarkers, TumorCase-Control StudiesFemaleFollow-Up StudiesHumansMaleMicroRNAsMiddle AgedPrognosisSodium-Iodide SymportersSymportersThyroid Cancer, PapillaryThyroid NeoplasmsTumor Cells, CulturedBiomarkers, TumorMicroRNAsMIrn181 microRNA, humanSodium-Iodide SymportersSymportersmicroRNAmiR-181a-5pNISpapillary thyroid carcinomaPTCSLC5A5thyroid carcinoma

Identifiers

PMID34199867
PMCPMC8200107
OpenAlexW3168132750

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.